J. JEFFERSON SMITH - 31 Aug 2023 Form 4 Insider Report for PRECISION BIOSCIENCES INC (DTIL)

Role
Chief Research Officer
Signature
/s/ Dario Scimeca, Attorney-in-Fact for J. Jefferson Smith
Issuer symbol
DTIL
Transactions as of
31 Aug 2023
Net transactions value
+$2,018
Form type
4
Filing time
05 Sep 2023, 16:15:14 UTC
Previous filing
09 Jun 2023
Next filing
23 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DTIL Common Stock Award $2,018 +5,175 +0.27% $0.3900 1,940,254 31 Aug 2023 Direct F1
holding DTIL Common Stock 237,959 31 Aug 2023 By Charitable Remainder Unitrust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired under the Issuer's 2019 Employee Stock Purchase Plan subsequent to the Reporting Person's Form 4 filed on June 9, 2023.